Allergan - U.S. Dermatology Portfolio's Unit Acquisition

Allergan - U.S. Dermatology Portfolio raised a round of funding on August 03, 2018. Investors include Almirall.

Allergan (NYSE: AGN), fka Actavis and before that Watson Pharmaceuticals, is a global pharmaceutical company focused on developing, manufacturing, and commercializing innovative branded pharmaceutical…

Articles about Allergan - U.S. Dermatology Portfolio's Unit Acquisition: